Ma. Harrington et al., INHIBITION OF COLONY-STIMULATING FACTOR-I PROMOTER ACTIVITY BY THE PRODUCT OF THE WILMS-TUMOR LOCUS, The Journal of biological chemistry, 268(28), 1993, pp. 21271-21275
Colony-stimulating factor-1 (CSF-1) is a member of the immediate early
gene family, which is expressed in mitogen-stimulated quiescent fibro
blasts. The biological effects of CSF-1 are multifaceted and include s
timulation of the proliferation and differentiation of myeloid progeni
tors and activity of circulating monocytes and tissue-specific macroph
ages. Ablation of circulating levels of biologically active CSF-1 in m
ice leads to osteopetrosis and sterility, thus implicating a role for
CSF-1 in bone remodeling and implantation. Identification of regulator
y elements and cognate transcription factors that bind the csf-1 promo
ter and mediate such diverse expression patterns is of great interest.
We identified a sequence element at -273 to -265 (relative to the tra
nscription initiation site) in the murine csf-1 promoter, which contai
ns overlapping consensus sequences for the Wilms' tumor protein (WT1),
EGR-1, SP1, and SP3 proteins. WT1 and EGR-1 proteins produced in vitr
o bound to this sequence, and co-transfection of wt1 with a csf-1-cat
reporter plasmid resulted in repression of promoter activity. Interest
ingly, nuclear extracts prepared from serum-stimulated C3H10T1/2 cells
contained predominantly SP1 and SP3 binding activities, which recogni
zed the -273 to -265 site. Thus repression of the csf-1 promoter by WT
1 at this site may involve competition between SP1 family transcriptio
nal activators and the WT1 repressor. Colony-stimulating factor-1 may
be a physiologically relevant target gene for regulation by the WT1 tr
anscription factor.